(Q50966044)

26 March 2018

title

Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma. (English)

1 reference

26 March 2018

author name string

Ye Cao

1

1 reference

26 March 2018

Yan-xia Shi

2

1 reference

26 March 2018

Jing-ou Chen

3

1 reference

26 March 2018

Yu-ting Tan

4

1 reference

26 March 2018

Yu-Chen Cai

5

1 reference

26 March 2018

Hui-yan Luo

6

1 reference

26 March 2018

Miao-zhen Qiu

7

1 reference

26 March 2018

Xiu-yu Cai

8

1 reference

26 March 2018

Ying Jin

9

1 reference

26 March 2018

Yue-li Sun

10

1 reference

26 March 2018

Wen-qi Jiang

11

1 reference

26 March 2018

publication date

11 February 2012

1 reference

26 March 2018

published in

Tumor Biology

1 reference

26 March 2018

volume

33

1 reference

26 March 2018

issue

4

1 reference

26 March 2018

page(s)

1039-1044

1 reference

26 March 2018

https://scigraph.springernature.com/pub.10.1007/s13277-012-0337-z

exact match

0 references

cites work

C-reactive protein: ligands, receptors and role in inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

Phylogenetic perspectives in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

C-reactive protein in atherosclerosis: A causal factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

C-reactive protein and the risk of incident colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

A systematic review of the association between circulating concentrations of C reactive protein and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

Impact of C-reactive protein on treatment of patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0337-Z

Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?

21 January 2018

1 reference

12 December 2020

C-reactive protein: the best laboratory indicator available for monitoring disease activity

1 reference

12 December 2020

C-reactive protein is a prognostic parameter in patients with cervical cancer

1 reference

12 December 2020

Evaluation of some biochemical markers as prognostic factors in malignant lymphoma

1 reference

12 December 2020

Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer

1 reference

12 December 2020

Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma

1 reference

12 December 2020

C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma

1 reference

12 December 2020

Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer

1 reference

12 December 2020

The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma

1 reference

12 December 2020

Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma

1 reference

12 December 2020

An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.

1 reference

12 December 2020

10.1007/S13277-012-0337-Z

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018